First, we analyzed whether fluvastatin could affect CD20 expression on the lymphoma tumor cell lines C1R and Raji and on primary CLL (n = 10) or HER2 expression on breast adenocarcinoma cell lines SKBR3 and BT474. Here, ERBB2 is linked to neoplasm.